Tech Transfer eNews Blog
University-Industry Engagement Advisor

U of Maryland-Baltimore start-up licenses decision-making support system for health care workers

By Jesse Schwartz
Published: July 22nd, 2020

A University of Maryland-Baltimore (UMB) start-up has developed a system that combines AI with traditional methods to arm healthcare professionals with the best data to provide personalized treatment trajectories for their patients.

Pumas-AI aims to help healthcare professionals make faster, more informed decisions about patient care with its support system Lyv. The technology leverages clinical research and electronic health records from millions of patients to derive algorithms that can personalize health care delivery. The UMB Office of Technology Transfer (OTT) has granted Pumas-AI a worldwide, exclusive license Lyv.

According to UMB professor of pediatrics Adnan Bhutta, a technology like Lyv would be helpful in many clinical settings.

“As a pediatric intensivist, it is critically important that we do everything we can to maximize the safety of our patients. Automation technology and the use of decision support tools can be valuable in this process,” Bhutta says. “This is particularly true in a high stress environment like an intensive care unit, where health care providers are asked to make hundreds of decisions around patient care on a daily basis.”

“This could be a revolutionary new tool for health care providers, potentially informing real-time decisions about patient treatments,” says Phil Robilotto, associate vice president of UMB’s tech transfer office.

“Our vision is to greatly improve pharmaceutical and patient care success and reduce dosing errors,” says Joga Gobburu, professor at UMB and CEO of Pumas-AI. “This licensing agreement brings us one step closer to achieving that goal.”

Source: Baltimore Business Journal

Posted under: Tech Transfer e-News

Twitter Facebook Linkedin Pinterest Email

No Comments so far ↓

There are no comments yet...Kick things off by filling out the form below.

Leave a Comment